These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 8743334

  • 1. Clinical pharmacokinetics of therapeutic bile acids.
    Crosignani A, Setchell KD, Invernizzi P, Larghi A, Rodrigues CM, Podda M.
    Clin Pharmacokinet; 1996 May; 30(5):333-58. PubMed ID: 8743334
    [Abstract] [Full Text] [Related]

  • 2. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K, Hohenester S, Winkler-Budenhofer U, Bastiaansen BA, Schaap FG, Rust C, Beuers U.
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolism of sulfonate analogs of ursodeoxycholic acid and their effects on biliary bile acid composition in hamsters.
    Mikami T, Kihira K, Ikawa S, Yoshii M, Miki S, Mosbach EH, Hoshita T.
    J Lipid Res; 1993 Mar; 34(3):429-35. PubMed ID: 8468526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M, Colombo C, Setchell KD.
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [Abstract] [Full Text] [Related]

  • 10. The continuing importance of bile acids in liver and intestinal disease.
    Hofmann AF.
    Arch Intern Med; 1990 Aug; 159(22):2647-58. PubMed ID: 10597755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
    Stiehl A.
    Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New therapeutical indications of ursodeoxycholic acid.
    Copaci I, Micu L, Iliescu L, Voiculescu M.
    Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
    [Abstract] [Full Text] [Related]

  • 18.
    ; 2012 Sep. PubMed ID: 31643938
    [Abstract] [Full Text] [Related]

  • 19. Radiosynthesis of N-¹¹C-Methyl-Taurine-Conjugated Bile Acids and Biodistribution Studies in Pigs by PET/CT.
    Schacht AC, Sørensen M, Munk OL, Frisch K.
    J Nucl Med; 2016 Apr; 57(4):628-33. PubMed ID: 26697965
    [Abstract] [Full Text] [Related]

  • 20. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
    Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjövall J.
    J Clin Invest; 1992 Jun; 89(6):1981-7. PubMed ID: 1602004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.